GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcell-Bio Therapeutics (XKRX:323990) » Definitions » Issuance of Stock

Vaxcell-Bio Therapeutics (XKRX:323990) Issuance of Stock : ₩0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcell-Bio Therapeutics Issuance of Stock?

Vaxcell-Bio Therapeutics's Issuance of Stock for the three months ended in Sep. 2024 was ₩0.0 Mil.

Vaxcell-Bio Therapeutics's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0.0 Mil.


Vaxcell-Bio Therapeutics Issuance of Stock Historical Data

The historical data trend for Vaxcell-Bio Therapeutics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcell-Bio Therapeutics Issuance of Stock Chart

Vaxcell-Bio Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Stock
1,299.74 29,366.24 597.38 - 71,789.74

Vaxcell-Bio Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vaxcell-Bio Therapeutics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaxcell-Bio Therapeutics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Vaxcell-Bio Therapeutics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxcell-Bio Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
12-55, Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Yeosu, KOR, 58141
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.

Vaxcell-Bio Therapeutics Headlines

No Headlines